Global Companion Diagnostics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	177 Pages	TechNavio	June, 2024	INF19006818

Best Price Guarantee
Price	from $2,500
Length	177 Pages
Publisher	TechNavio
Published Date	June, 2024
SKU	INF19006818

Global Companion Diagnostics Market 2024-2028

The companion diagnostics market is forecasted to grow by USD 28983.1 mn during 2023-2028, accelerating at a CAGR of 36.5% during the forecast period. The report on the companion diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising use of personalized medicine, increased industry collaborations, and growing investments in life sciences sector.

Technavio's companion diagnostics market is segmented as below:

ByEnd-user

Life science
Health centers
Others

ByIndication

Oncology
Neurology
Others

ByGeography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising occurrence of breast cancer as one of the prime reasons driving the companion diagnostics market growth during the next few years. Also, increase in product approvals to treat cancer and growing importance for promotional activities will lead to sizable demand in the market.

The report on the companion diagnostics market covers the following areas:

Companion diagnostics market sizing
Companion diagnostics market forecast
Companion diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion diagnostics market vendors that include Abbott Laboratories, Abnova Corp., Agilent Technologies Inc., Amoy Diagnostics Co. Ltd., ARUP Laboratories, Bayer AG, BioGenex Laboratories Inc., bioMerieux SA, F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Invivoscribe Inc., Liquid Biotech USA Inc., Myriad Genetics Inc., NG Biotech, QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc.. Also, the companion diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Indication; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Companion Diagnostics Market 2018 - 2022; Historic Market Size - Data Table on Global Companion Diagnostics Market 2018 - 2022 ($ million); 4.2 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.3 Indication segment analysis 2018 - 2022; Historic Market Size - Indication Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 6.3 Life science - Market size and forecast 2023-2028; Chart on Life science - Market size and forecast 2023-2028 ($ million); Data Table on Life science - Market size and forecast 2023-2028 ($ million); Chart on Life science - Year-over-year growth 2023-2028 (%); Data Table on Life science - Year-over-year growth 2023-2028 (%); 6.4 Health centers - Market size and forecast 2023-2028; Chart on Health centers - Market size and forecast 2023-2028 ($ million); Data Table on Health centers - Market size and forecast 2023-2028 ($ million); Chart on Health centers - Year-over-year growth 2023-2028 (%); Data Table on Health centers - Year-over-year growth 2023-2028 (%); 6.5 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Indication: 7.1 Market segments; Chart on Indication - Market share 2023-2028 (%); Data Table on Indication - Market share 2023-2028 (%); 7.2 Comparison by Indication; Chart on Comparison by Indication; Data Table on Comparison by Indication; 7.3 Oncology - Market size and forecast 2023-2028; Chart on Oncology - Market size and forecast 2023-2028 ($ million); Data Table on Oncology - Market size and forecast 2023-2028 ($ million); Chart on Oncology - Year-over-year growth 2023-2028 (%); Data Table on Oncology - Year-over-year growth 2023-2028 (%); 7.4 Neurology - Market size and forecast 2023-2028; Chart on Neurology - Market size and forecast 2023-2028 ($ million); Data Table on Neurology - Market size and forecast 2023-2028 ($ million); Chart on Neurology - Year-over-year growth 2023-2028 (%); Data Table on Neurology - Year-over-year growth 2023-2028 (%); 7.5 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Indication; Market opportunity by Indication ($ million); Data Table on Market opportunity by Indication ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.11 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ million); Data Table on France - Market size and forecast 2023-2028 ($ million); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 12.4 Abnova Corp.; Abnova Corp. - Overview; Abnova Corp. - Product / Service; Abnova Corp. - Key offerings; 12.5 Agilent Technologies Inc.; Agilent Technologies Inc. - Overview; Agilent Technologies Inc. - Business segments; Agilent Technologies Inc. - Key news; Agilent Technologies Inc. - Key offerings; Agilent Technologies Inc. - Segment focus; 12.6 Amoy Diagnostics Co. Ltd.; Amoy Diagnostics Co. Ltd. - Overview; Amoy Diagnostics Co. Ltd. - Product / Service; Amoy Diagnostics Co. Ltd. - Key offerings; 12.7 ARUP Laboratories; ARUP Laboratories - Overview; ARUP Laboratories - Product / Service; ARUP Laboratories - Key offerings; 12.8 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 12.9 BioGenex Laboratories Inc.; BioGenex Laboratories Inc. - Overview; BioGenex Laboratories Inc. - Product / Service; BioGenex Laboratories Inc. - Key offerings; 12.10 bioMerieux SA; bioMerieux SA - Overview; bioMerieux SA - Product / Service; bioMerieux SA - Key news; bioMerieux SA - Key offerings; 12.11 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.12 Illumina Inc.; Illumina Inc. - Overview; Illumina Inc. - Business segments; Illumina Inc. - Key news; Illumina Inc. - Key offerings; Illumina Inc. - Segment focus; 12.13 Myriad Genetics Inc.; Myriad Genetics Inc. - Overview; Myriad Genetics Inc. - Product / Service; Myriad Genetics Inc. - Key news; Myriad Genetics Inc. - Key offerings; 12.14 QIAGEN NV; QIAGEN NV - Overview; QIAGEN NV - Product / Service; QIAGEN NV - Key news; QIAGEN NV - Key offerings; 12.15 Siemens AG; Siemens AG - Overview; Siemens AG - Business segments; Siemens AG - Key news; Siemens AG - Key offerings; Siemens AG - Segment focus; 12.16 Sysmex Corp.; Sysmex Corp. - Overview; Sysmex Corp. - Business segments; Sysmex Corp. - Key news; Sysmex Corp. - Key offerings; Sysmex Corp. - Segment focus; 12.17 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations

Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Indication; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Companion Diagnostics Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Indication Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on End-user - Market share 2023-2028 (%); Exhibits33: Data Table on End-user - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by End-user; Exhibits35: Data Table on Comparison by End-user; Exhibits36: Chart on Life science - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Life science - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Life science - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Life science - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Health centers - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Health centers - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Health centers - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Health centers - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by End-user ($ million); Exhibits49: Data Table on Market opportunity by End-user ($ million); Exhibits50: Chart on Indication - Market share 2023-2028 (%); Exhibits51: Data Table on Indication - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Indication; Exhibits53: Data Table on Comparison by Indication; Exhibits54: Chart on Oncology - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Oncology - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Oncology - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Oncology - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Neurology - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Neurology - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Neurology - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Neurology - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits66: Market opportunity by Indication ($ million); Exhibits67: Data Table on Market opportunity by Indication ($ million); Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits71: Chart on Geographic comparison; Exhibits72: Data Table on Geographic comparison; Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits109: Market opportunity By Geographical Landscape ($ million); Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits111: Impact of drivers and challenges in 2023 and 2028; Exhibits112: Overview on criticality of inputs and factors of differentiation; Exhibits113: Overview on factors of disruption; Exhibits114: Impact of key risks on business; Exhibits115: Companies covered; Exhibits116: Matrix on companies position and classification; Exhibits117: Abbott Laboratories - Overview; Exhibits118: Abbott Laboratories - Business segments; Exhibits119: Abbott Laboratories - Key news; Exhibits120: Abbott Laboratories - Key offerings; Exhibits121: Abbott Laboratories - Segment focus; Exhibits122: Abnova Corp. - Overview; Exhibits123: Abnova Corp. - Product / Service; Exhibits124: Abnova Corp. - Key offerings; Exhibits125: Agilent Technologies Inc. - Overview; Exhibits126: Agilent Technologies Inc. - Business segments; Exhibits127: Agilent Technologies Inc. - Key news; Exhibits128: Agilent Technologies Inc. - Key offerings; Exhibits129: Agilent Technologies Inc. - Segment focus; Exhibits130: Amoy Diagnostics Co. Ltd. - Overview; Exhibits131: Amoy Diagnostics Co. Ltd. - Product / Service; Exhibits132: Amoy Diagnostics Co. Ltd. - Key offerings; Exhibits133: ARUP Laboratories - Overview; Exhibits134: ARUP Laboratories - Product / Service; Exhibits135: ARUP Laboratories - Key offerings; Exhibits136: Bayer AG - Overview; Exhibits137: Bayer AG - Business segments; Exhibits138: Bayer AG - Key news; Exhibits139: Bayer AG - Key offerings; Exhibits140: Bayer AG - Segment focus; Exhibits141: BioGenex Laboratories Inc. - Overview; Exhibits142: BioGenex Laboratories Inc. - Product / Service; Exhibits143: BioGenex Laboratories Inc. - Key offerings; Exhibits144: bioMerieux SA - Overview; Exhibits145: bioMerieux SA - Product / Service; Exhibits146: bioMerieux SA - Key news; Exhibits147: bioMerieux SA - Key offerings; Exhibits148: F. Hoffmann La Roche Ltd. - Overview; Exhibits149: F. Hoffmann La Roche Ltd. - Business segments; Exhibits150: F. Hoffmann La Roche Ltd. - Key news; Exhibits151: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits152: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits153: Illumina Inc. - Overview; Exhibits154: Illumina Inc. - Business segments; Exhibits155: Illumina Inc. - Key news; Exhibits156: Illumina Inc. - Key offerings; Exhibits157: Illumina Inc. - Segment focus; Exhibits158: Myriad Genetics Inc. - Overview; Exhibits159: Myriad Genetics Inc. - Product / Service; Exhibits160: Myriad Genetics Inc. - Key news; Exhibits161: Myriad Genetics Inc. - Key offerings; Exhibits162: QIAGEN NV - Overview; Exhibits163: QIAGEN NV - Product / Service; Exhibits164: QIAGEN NV - Key news; Exhibits165: QIAGEN NV - Key offerings; Exhibits166: Siemens AG - Overview; Exhibits167: Siemens AG - Business segments; Exhibits168: Siemens AG - Key news; Exhibits169: Siemens AG - Key offerings; Exhibits170: Siemens AG - Segment focus; Exhibits171: Sysmex Corp. - Overview; Exhibits172: Sysmex Corp. - Business segments; Exhibits173: Sysmex Corp. - Key news; Exhibits174: Sysmex Corp. - Key offerings; Exhibits175: Sysmex Corp. - Segment focus; Exhibits176: Thermo Fisher Scientific Inc. - Overview; Exhibits177: Thermo Fisher Scientific Inc. - Business segments; Exhibits178: Thermo Fisher Scientific Inc. - Key news; Exhibits179: Thermo Fisher Scientific Inc. - Key offerings; Exhibits180: Thermo Fisher Scientific Inc. - Segment focus; Exhibits181: Inclusions checklist; Exhibits182: Exclusions checklist; Exhibits183: Currency conversion rates for US$; Exhibits184: Research methodology; Exhibits185: Information sources; Exhibits186: Data validation; Exhibits187: Validation techniques employed for market sizing; Exhibits188: Data synthesis; Exhibits189: 360 degree market analysis; Exhibits190: List of abbreviations